Parkinson's Disease Trial, Recruiting (NCT02763683)

Parkinson's Disease Trial, Recruiting NCT02763683 Sponsor: Washington University School of Medicine Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT02763683 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Parkinson's disease and show at least three of these symptoms: tremor at rest, muscle stiffness, slowness of movement, or problems with balance — or at least two of these symptoms where one side of your body is more affected than the other.

Who may not be able to join:

You have a history of a serious head injury, or have another significant brain, nerve, or mental health condition besides Parkinson's disease or dementia — for example, stroke, multiple sclerosis, depression, or schizophrenia.
You have a serious illness affecting other parts of your body (confirm with trial site).
You are unable to lie still for 90 minutes, for example due to pain or severe movement difficulties.
You have metal implants, a pacemaker, or any other reason why having an MRI scan would not be safe for you.
You are not willing to agree to donate your brain for research after death.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joel S Perlmutter, MD, Washington University School of Medicine

Phone: 314 273 8313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02763683

Sponsor: Washington University School of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 314 273 8313

More information: https://clinicaltrials.gov/study/NCT02763683

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Parkinson's disease and show at least three of these symptoms: tremor at rest, muscle stiffness, slowness of movement, or problems with balance — or at least two of these symptoms where one side of your body is more affected than the other.

Who may not be able to join:

You have a history of a serious head injury, or have another significant brain, nerve, or mental health condition besides Parkinson's disease or dementia — for example, stroke, multiple sclerosis, depression, or schizophrenia.
You have a serious illness affecting other parts of your body (confirm with trial site).
You are unable to lie still for 90 minutes, for example due to pain or severe movement difficulties.
You have metal implants, a pacemaker, or any other reason why having an MRI scan would not be safe for you.
You are not willing to agree to donate your brain for research after death.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Washington University School of Medicine

Registry

ClinicalTrials.gov

Start date

1 June 2016

Est. completion

1 March 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Investigations of Dementia in Parkinsons Disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov